This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Jim Middelburg
.. at Leiden University Medical Center

Profile

I started my research career with the Drug Innovation Master at the University of Utrecht. There, I performed internships in the fields of allergy, immuno-oncology and bispecific antibody engineering. These internships allowed me to obtain a PhD position in the group of Thorbald van Hall in collaboration with Genmab. In my PhD project I am happily investigating strategies to improve CD3-bispecific antibody therapy in solid tumors in mice.

Agenda Sessions

  • CD3-bispecific Antibody Therapy is Effective in Solid Tumors after Increased T cell Infiltration Induced by Vaccines

    14:25